Middle East & Africa Veterinary Neurodegenerative Disease Diagnostics Market Size & Outlook

The veterinary neurodegenerative disease diagnostics market in Middle East & Africa is expected to reach a projected revenue of US$ 13.3 million by 2030. A compound annual growth rate of 9.3% is expected of Middle East & Africa veterinary neurodegenerative disease diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$7.9
Forecast, 2030 (US$M)
$13.3
CAGR, 2025 - 2030
9.3%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa veterinary neurodegenerative disease diagnostics market, 2018-2030 (US$M)

Middle East & Africa veterinary neurodegenerative disease diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

MEA veterinary neurodegenerative disease diagnostics market highlights

  • The MEA veterinary neurodegenerative disease diagnostics market generated a revenue of USD 7.9 million in 2024.
  • The market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
  • In terms of segment, biomarker diagnostic tests was the largest revenue generating diagnostic tests in 2024.
  • Biomarker Diagnostic Tests is the most lucrative diagnostic tests segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.


MEA data book summary

Market revenue in 2024USD 7.9 million
Market revenue in 2030USD 13.3 million
Growth rate9.3% (CAGR from 2025 to 2030)
Largest segmentBiomarker diagnostic tests
Fastest growing segmentBiomarker Diagnostic Tests
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImaging, Biomarker Diagnostic Tests, Other Diagnostic tests


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.2% of the global veterinary neurodegenerative disease diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 132.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Neurodegenerative Disease Diagnostics Market Companies

Name Profile # Employees HQ Website
MRN View profile 11-50 Cleveland, Ohio, United States, North America https://www.mrnltd.com
Acuvate View profile 251-500 Hyderabad, Andhra Pradesh, India, Asia https://acuvate.com/
Mercodia View profile 51-100 Uppsala, Uppsala Lan, Sweden, Europe http://www.mercodia.com
Life Diagnostics View profile 1-10 West Chester, Pennsylvania, United States, North America http://lifediagnostics.com
Avacta Group PLC View profile 113 Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, United Kingdom, LS23 7FA https://www.avacta.com
Antech Diagnostics View profile 1001-5000 Irvine, California, United States, North America https://www.antechdiagnostics.com
IDEXX Laboratories Inc View profile 11000 One IDEXX Drive, Westbrook, ME, United States, 04092 https://www.idexx.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Middle East & Africa veterinary neurodegenerative disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary neurodegenerative disease diagnostics market will help companies and investors design strategic landscapes.


Biomarker diagnostic tests was the largest segment with a revenue share of 53.16% in 2024. Horizon Databook has segmented the Middle East & Africa veterinary neurodegenerative disease diagnostics market based on imaging, biomarker diagnostic tests, other diagnostic tests covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Middle East & Africa veterinary neurodegenerative disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa veterinary neurodegenerative disease diagnostics market databook

  • Our clientele includes a mix of veterinary neurodegenerative disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa veterinary neurodegenerative disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa veterinary neurodegenerative disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA veterinary neurodegenerative disease diagnostics market size, by country, 2018-2030 (US$M)

Middle East & Africa Veterinary Neurodegenerative Disease Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

MEA veterinary neurodegenerative disease diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online